市場調査レポート
商品コード
1410895
緑内障手術機器の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、処置、予測(~2033年)Glaucoma Surgery Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
緑内障手術機器の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、処置、予測(~2033年) |
出版日: 2023年12月12日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
世界中での緑内障の発症率と有病率の増加や高齢化が不可逆的な失明の主因となっており、不可逆的な失明を阻止する最良の予防策は、眼から液体を排出することです。このため、バルブ付きおよびバルブなしのドレナージ機器の売上が増加すると予測されます。
緑内障手術機器は欧米市場において長い歴史を持ち、アジア太平洋や南米などの新興市場でも定着しています。
当レポートでは、世界の緑内障手術機器市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。
市場モデルの主な内容は以下の通りです。
上市済みの緑内障手術機器と進化する競合情勢
世界、地域、国レベルの市場固有の考察
医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。
対象企業
Not Applicable
Not Applicable
Glaucoma Surgery Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Glaucoma Surgery Devices market for the year 2020 and beyond. Aging population coupled with increase in incidence and prevalence of glaucoma globally is the leading cause of irreversible vision loss, and best preventive measure to stop the irreversible vision loss is drainage of fluids from the eyes. This is expected to increase sales of valved and non-valved drainage devices.
Glaucoma Surgery Devices have a long history of use in the US and European markets and are well established in emerging markets such as APAC and South America.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Glaucoma Surgery Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Glaukos Corp, AbbVie Inc, Alcon Inc, Johnson & Johnson, New World Medical, Incorporated, Aurolab, Santen Pharmaceutical Co Ltd, Nova Eye Medical Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable